Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Drugs for insomnia.

Zisapel N.

Expert Opin Emerg Drugs. 2012 Sep;17(3):299-317. doi: 10.1517/14728214.2012.690735. Epub 2012 Jun 11. Review.

PMID:
22681198
2.

Current Phase II investigational therapies for insomnia.

Zisapel N.

Expert Opin Investig Drugs. 2015 Mar;24(3):401-11. doi: 10.1517/13543784.2015.987340. Epub 2014 Nov 25. Review.

PMID:
25423562
3.

Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time.

Wafford KA, Ebert B.

Nat Rev Drug Discov. 2008 Jun;7(6):530-40. doi: 10.1038/nrd2464. Epub 2008 May 23. Review.

PMID:
18511929
4.

Pharmacotherapy of insomnia.

Ioachimescu OC, El-Solh AA.

Expert Opin Pharmacother. 2012 Jun;13(9):1243-60. doi: 10.1517/14656566.2012.683860. Epub 2012 May 11. Review.

PMID:
22578014
5.

Emerging drugs for insomnia: new frontiers for old and novel targets.

Sullivan SS, Guilleminault C.

Expert Opin Emerg Drugs. 2009 Sep;14(3):411-22. doi: 10.1517/14728210903171948. Review.

PMID:
19708818
6.

Update on emerging drugs for insomnia.

Sullivan S.

Expert Opin Emerg Drugs. 2012 Sep;17(3):295-8. doi: 10.1517/14728214.2012.693158.

PMID:
22920041
7.

Discovery and development of orexin receptor antagonists as therapeutics for insomnia.

Winrow CJ, Renger JJ.

Br J Pharmacol. 2014 Jan;171(2):283-93. doi: 10.1111/bph.12261. Review.

8.

Main neuroendocrine features and therapy in primary sleep troubles.

Amihăesei IC, Mungiu OC.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):862-6.

PMID:
23272543
9.

Pharmacotherapy of insomnia.

Bhat A, Shafi F, El Solh AA.

Expert Opin Pharmacother. 2008 Feb;9(3):351-62. doi: 10.1517/14656566.9.3.351 . Review.

PMID:
18220487
10.

Sleep complaints: Whenever possible, avoid the use of sleeping pills.

[No authors listed]

Prescrire Int. 2008 Oct;17(97):206-12.

PMID:
19536941
11.

New and emerging pharmacotherapeutic approaches for insomnia.

Neubauer DN.

Int Rev Psychiatry. 2014 Apr;26(2):214-24. doi: 10.3109/09540261.2014.888990. Review.

PMID:
24892896
12.

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.

Dündar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T.

Health Technol Assess. 2004 Jun;8(24):iii-x, 1-125. Review.

13.

[Present status and future of hypnotic drug treatment for insomnia].

Uchiyama M, Konno M.

Nihon Rinsho. 2012 Jul;70(7):1241-51. Review. Japanese.

PMID:
22844812
14.

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):913-23. doi: 10.1016/j.pnpbp.2011.03.013. Epub 2011 Mar 29. Review.

PMID:
21453740
15.

Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.

Lemoine P, Zisapel N.

Expert Opin Pharmacother. 2012 Apr;13(6):895-905. doi: 10.1517/14656566.2012.667076. Epub 2012 Mar 19. Review.

PMID:
22429105
16.

Therapeutic options for sleep-maintenance and sleep-onset insomnia.

Morin AK, Jarvis CI, Lynch AM.

Pharmacotherapy. 2007 Jan;27(1):89-110. Review.

PMID:
17192164
18.

Treating insomnia: Current and investigational pharmacological approaches.

Ebert B, Wafford KA, Deacon S.

Pharmacol Ther. 2006 Dec;112(3):612-29. Epub 2006 Jul 28. Review.

PMID:
16876255
19.

Pharmacological advances in the treatment of insomnia.

Richey SM, Krystal AD.

Curr Pharm Des. 2011;17(15):1471-5. Review.

PMID:
21476952
20.

Management of chronic insomnia in elderly persons.

Bain KT.

Am J Geriatr Pharmacother. 2006 Jun;4(2):168-92. Review.

PMID:
16860264

Supplemental Content

Support Center